Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility
- 1 October 1996
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 62 (4), 1134-1140
- https://doi.org/10.1016/0003-4975(96)00492-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Differences in blood activation related to roller/centrifugal pumps and heparin coated/uncoated surfaces in a cardiopulmonary bypass model circuitPerfusion, 1996
- Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activationPerfusion, 1994
- Effect of Surface‐Immobilized Heparin on the Activation of Adsorbed Factor XIIArtificial Organs, 1993
- Analysis of serial measurements in medical research.BMJ, 1990
- SP-40,40 is an inhibitor of C5b-6-initiated haemolysisInternational Immunology, 1989
- Quantification in Enzyme‐Linked Immunosorbent Assay of a C3 Neoepitope Expressed on Activated Human Complement Factor C3Scandinavian Journal of Immunology, 1988
- Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary BypassNew England Journal of Medicine, 1988
- Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol groupBiochemistry, 1985
- Serum Myeloperoxidase and Lactoferrin in NeutropeniaScandinavian Journal of Haematology, 1977
- A Method for Determination of Hemoglobin in Plasma by Near-Ultraviolet SpectrophotometryScandinavian Journal of Clinical and Laboratory Investigation, 1959